Golchin, A., Farahany, T.Z., Khojasteh, A., et al. (2019) The Clinical Trials of Mesenchymal Stem Cell Therapy in Skin Diseases: An Update and Concise Review. Current Stem Cell Research & Therapy, 14, 22-33.
https://doi.org/10.2174/1574888X13666180913123424

has been cited by the following article:

• TITLE: Improvement of Atrophic Acne Scar and Skin Complexity by Combination of Aqueous Human Placenta Extract and Mesenchymal Stem Cell Mesotherapy

  AUTHORS: Ruchee Phonchai, Pimjai Naigowit, Bunchob Ubonsaen, Supansa Nilubol, Supaluk Brameld, Parinya Noisa

  KEYWORDS: Atrophic Scar, Mesenchymal Stem Cells, Human Placenta Extract, Mesotherapy, Skin, Regeneration

  JOURNAL NAME: Journal of Cosmetics, Dermatological Sciences and Applications, Vol.10 No.1, January 22, 2020

  ABSTRACT: Atrophic scars, a permanent complication of severe acne, have negative effect on psychology in adolescent. The treatment of atrophic scar is depended on types of scar and it is difficult to improve by a single treatment. Mesenchymal stem cell is a scientific approval for surgery scar treatment and wound healing. We present a case report of female presented with atrophic acne scar distributed on both cheeks. The case aims to prove that the combination of MSCs and aqueous human placenta extract (RGF®) contained bioactive therapeutic molecules obviously promoted the improvement of skin scar to reach the optimal outcomes. We first found that MSCs-contained human placenta extract solution combination subcision improves the atrophic acne scar and skin complexity by enhancement of skin cell regeneration.